Typhoid Antibody Testing Market Size & Share, by Product Type {WIDAL Test, Typhidot Test, Rapid Serological Tests (Counter Immunoelectrophoresis, Hem-agglutination & Co-agglutination)}; End-user (Serological Testing Centers, Hospitals, Diagnostic Centers, Clinics, Other Healthcare Facilities) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4164
  • Published Date: Aug 10, 2023
  • Report Format: PDF, PPT

Companies Dominating the Typhoid Antibody Testing Market

top-features-companies
    • IDL Biotech AB
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • LINEAR CHEMICALS, S.L.U
    • Medical Innovation Ventures Sdn Bhd
    • Thermo Fisher Scientific
    • Nectar Lifesciences Ltd.
    • DIALAB GmbH.
    • BIOSYSTEMS S.A.
    • Siemens Healthcare GmbH
    • NanoEnTek
    • CerTest Biotec S.L.

Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • IDL Biotech AB launched TUBEX TF, a rapid test for typhoid fever in Kenya. Launch took place at Kenya Medical Research Institute in the presence of doctors, pathologists, and representatives from the Ministry of Health.
  • BD launched a new automated cytometry system. The system enhances efficiency by reducing the chances of errors and reducing human intervention

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4164
  • Published Date: Aug 10, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Typhoid is on the rise in developing countries and increased competition among top competitors to produce fast and cost-effective diagnostic kits to diagnose typhoid cases is anticipated to boost the market growth.

The market is anticipated to attain a CAGR of 7% over the forecast period i.e., 2023 – 2035.

The market in Asia Pacific is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are LINEAR CHEMICALS, S.L.U, Medical Innovation Ventures Sdn Bhd, Thermo Fisher Scientific, Nuclear Lifesciences Ltd., DIALAB GmbH., BIOSYSTEMS S.A., and others.

The hospital segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying